What is the price target for BIOR stock?
7 analysts have analysed BIOR and the average price target is 34.68 USD. This implies a price increase of 6096.18% is expected in the next year compared to the current price of 0.5597.
BIORA THERAPEUTICS INC (BIOR) Forecast, Price Target & Analyst Ratings
NASDAQ:BIOR • US74319F3055
Current stock price
0.5597 USD
-0.79 (-58.54%)
At close:
0.579 USD
+0.02 (+3.45%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIORA THERAPEUTICS INC (BIOR).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- N/A
- Period
- Q4 / 2024
- EPS Estimate
- -$3.37
- Revenue Estimate
- 102K
Price Target Details & History
Consensus Price Target and Range
Mean target
$34.68
Upside
+ 6,096.18%
From current price of $0.56 to mean target of $34.68, Based on 7 analyst forecasts
Low
$23.23
Median
$34.68
High
$47.25
Price Target Revisions
1 Month
0.00%
3 Months
248.72%
Price Target Summary
7 Wall Street analysts provided a forecast for the next 12 months for BIOR. The average price target is 34.68 USD. This implies a price increase of 6096.18% is expected in the next year compared to the current price of 0.5597.
The average price target has been revised upward by 248.72% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
82.86%
BIOR was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about BIOR.
In the previous month the buy percentage consensus was at a similar level.
BIOR was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-11-18 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-08-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-01-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-10-02 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-07-27 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-01-10 | HC Wainwright & Co. | Maintains | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
- Period
- Q4 / 2024
- EPS Estimate
- -$3.37
- Revenue Estimate
- 102K
- Revenue Q2Q
- N/A
- EPS Q2Q
- 45.71%
- Number of Analysts
- 4
Next Earnings Revisions
Revenue (1 Month)
-54.55%
Revenue (3 Months)
N/A
EPS (1 Month)
10.81%
EPS (3 Months)
-695.18%
Next Earnings Summary
Full Analyst Estimates 2024 - 2026
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.2M 500.00% | 300K -75.00% | 4K -98.67% | 1M 24,890.00% | 2.553M 155.40% | 2.818M 10.38% | |
| EBITDA YoY % growth | -116.36M -13.48% | -60.89M 47.67% | -66.588M -9.36% | -66.912M -0.49% | -69.564M -3.96% | -79.356M -14.08% | |
| EBIT YoY % growth | -117.8M -9.48% | -61.8M 47.54% | -67.143M -8.65% | -63.569M 5.32% | -64.834M -1.99% | -71.601M -10.44% | |
| Operating Margin | -9,816.67% | -20,600.00% | -1,678,575.00% | -6,359.49% | -2,539.51% | -2,540.86% | |
| EPS YoY % growth | -557.50 64.98% | -51.40 90.78% | N/A -60.44% | -9.25 88.79% | -7.46 19.31% | -6.54 12.37% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 24 | |
|---|---|
| EPS Q2Q % growth | -3.37 45.71% |
| Revenue Q2Q % growth | 102K |
| EBITDA Q2Q % growth | -18.462M -44.36% |
| EBIT Q2Q % growth | -14.044M -5.25% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
24.30%
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
933.87%
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
-5.74%
EBIT Next 5 Year
N/A
BIORA THERAPEUTICS INC / BIOR Forecast FAQ
What are the consensus estimates for BIORA THERAPEUTICS INC (BIOR) next earnings?
The consensus EPS estimate for the next earnings of BIORA THERAPEUTICS INC (BIOR) is -3.37 USD and the consensus revenue estimate is 102.00K USD.
Can you provide the expected long term growth rate for BIORA THERAPEUTICS INC stock?
The expected long term growth rate for BIORA THERAPEUTICS INC (BIOR) is 933.87%.